Department of Child and Adolescent Psychiatry, Helse Fonna Haugesund Hospital, Haugesund 5501, Norway.
BMC Psychiatry. 2012 Aug 10;12:107. doi: 10.1186/1471-244X-12-107.
A randomized and controlled clinical study was performed to evaluate the use of neurofeedback (NF) to treat attention-deficit/hyperactivity disorder (ADHD) in children and adolescents.
The ADHD population was selected from an outpatient clinic for Child and Adolescent Mental Health in Norway. Ninety-one of the 275 children and adolescents ranging in age from 6 to 18 years (10.5 years) participated in 30 sessions of an intensive NF program. The reinforcement contingency was based on the subjects' production of cortical beta1 activity (15-18 Hz). The ADHD participants were randomized into three groups, with 30 in the NF group, 31 controls in a group that was given methylphenidate, and 30 in a group that received NF and methylphenidate. ADHD core symptoms were reported by parents using the parent form of the Clinician's Manual for Assessment by Russell A. Barkley.
Ninety-one children and adolescents were effectively randomized by age, sex, intelligence and distribution of ADHD core symptoms. The parents reported significant effects of the treatments, but no significant differences between the treatment groups were observed.
NF was as effective as methylphenidate at treating the attentional and hyperactivity symptoms of ADHD, based on parental reports.
Current Controlled Trials NCT01252446.
一项随机对照临床试验旨在评估神经反馈（NF）治疗儿童和青少年注意缺陷多动障碍（ADHD）的效果。
ADHD 患者从挪威儿童和青少年心理健康门诊中选取。91 名年龄在 6 至 18 岁（10.5 岁）之间的儿童和青少年参加了 30 次强化 NF 项目。强化的条件是根据主体产生的皮质β1 活动（15-18Hz）。ADHD 参与者随机分为三组，NF 组 30 人，接受利他林治疗的对照组 31 人，NF 和利他林联合治疗组 30 人。ADHD 核心症状由父母使用 Russell A. Barkley 临床医师手册评估的家长形式报告。
91 名儿童和青少年按年龄、性别、智力和 ADHD 核心症状分布有效随机分组。父母报告治疗有显著效果，但治疗组之间没有观察到显著差异。
根据父母的报告，NF 治疗 ADHD 的注意力和多动症状与利他林一样有效。
当前对照试验 NCT01252446。
